Normal life expectancy after all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Saved in:
Bibliographic Details
Title: Normal life expectancy after all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
Authors: Piciocchi A; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy. a.piciocchi@gimema.it., Talone A; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy., Messina M; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy., de Fabritiis P; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy., Marsili G; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy., Sargentini V; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy., Soddu S; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy., Cicconi L; Department of Hematology, Santa Maria Goretti Hospital, Polo Universitario Pontino, Latina, Italy., Guarnera L; Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy., Divona MD; Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy., Musto P; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico and Department of Precision and Regenerative Medicine and Ionian Area, Aldo Moro University School of Medicine, Bari, Italy., Ferrara F; Ematologia, AORN A. Cardarelli, Napoli, Italy., D'Ardia S; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Borlenghi E; SC di Ematologia, ASST Spedali Civili, Brescia, Italy., Buccisano F; Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy., Breccia M; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Efficace F; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy., Fazi P; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy., Venditti A; Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy., Coco FL; Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy., Platzbecker U; Department of Hematology, Oncology and Stem cell Transplantation, University Hospital, Leipzig, Germany., Vignetti M; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy., Voso MT; Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
Source: Leukemia [Leukemia] 2026 Jul; Vol. 40 (7), pp. 1532-1534. Date of Electronic Publication: 2026 Jun 08.
Publication Type: Letter
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-026-02989-0